Genetic ancestry was not tied to worse MS disability

Genetic ancestry was not tied to worse MS disability
Credibility
Interest
Share:1 min read
Key Takeaway

In this UK study, African and South Asian genetic ancestry were not consistently linked to worse MS disability than European ancestry.

What They Found

Researchers compared MS disability across people with different genetic ancestries. African ancestry was not consistently linked to worse disability than European ancestry. The same was true for South Asian ancestry. The researchers also looked for inherited gene differences linked to MS disability. They found no gene differences with a strong enough link to meet their study's threshold.

Who Should Care and Why

This study included adults with MS living in the United Kingdom. It compared people with African, South Asian, European, and other genetic ancestries. The findings speak to whether ancestry helps explain differences in MS disability. African and South Asian ancestry were not consistently linked to greater disability than European ancestry. The researchers said their findings argue against a genetic explanation for previously observed differences in MS outcomes between ethnic groups.

Important Considerations

You should know this study included 816 people and measured their health at one point in time. Participants reported their own MS characteristics, including disability and age at diagnosis. The findings do not show whether ancestry affects how your MS changes over time.

AI-generated summary — for informational purposes only, not medical advice

You May Also Like

Childhood MS blood patterns linked to Epstein-Barr virus
Childhood MS blood patterns linked to Epstein-Barr virus

11/1/2026

Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN

Read More
Stem Cell Treatment May Calm MS Brain Inflammation
Stem Cell Treatment May Calm MS Brain Inflammation

11/1/2026

In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for

Read More
New Brain Scans May Reveal Hidden Inflammation in MS
New Brain Scans May Reveal Hidden Inflammation in MS

11/1/2026

A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method

Read More
MS and Pregnancy: What to Know About Pausing Treatment
MS and Pregnancy: What to Know About Pausing Treatment

11/1/2026

In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t

Read More
MS Look-Alikes: Which Treatments May Help Prevent Attacks
MS Look-Alikes: Which Treatments May Help Prevent Attacks

10/16/2026

Two rare conditions can look like MS. An Italian study links certain treatments to more time without

Read More
Could an Extra Treatment Help Keep MS Quiet After Transplant?
Could an Extra Treatment Help Keep MS Quiet After Transplant?

10/15/2026

Researchers suggest adding a drug after stem cell transplant to help keep MS from returning. Learn h

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.